FDORA — Predetermined Change Control Plans for AI/ML Medical Devices
United States (Federal) | H.R. 2617 (Pub. L. 117-328), Div. FF, Title III, Section 3308
Categories
Key Requirements
Adds Section 515C to the FD&C Act authorizing FDA to approve predetermined change control plans (PCCPs) for medical devices. Manufacturers with an approved PCCP can update AI-enabled device software without submitting a new application for each modification, as long as changes are consistent with the pre-approved plan.
Regulated Parties
AI/ML medical device manufacturers seeking 510(k) clearance, De Novo authorization, or PMA approval
Enforcement
FDA (Center for Devices and Radiological Health)
Sources
Notes
Critical statutory authority for adaptive AI/ML medical devices. FDA issued final PCCP guidance on December 3, 2024, specifically for AI-enabled device software functions.
Companies Affected
Related Wiki Pages
- $100M, $40M, $20M: What 14 Health Systems Got Back from Their Tech Bets
- 25 Healthcare AI Use Cases — Comprehensive Overview with Examples
- 3 Things Healthcare Leaders Should Know About AI-Native EHRs
- Abridge — AI Decision Support Expansion for Clinicians
- AdvaMed Encourages Risk-Based FDA Approach to Generative AI Medical Devices
Want full access to all legislation details?
Upgrade to a Subscriber plan for unlimited law detail views, the state map, and upcoming effective date tracking.
View Plans